Back to Search
BASSEM ATASSI MD
MD
Urology Physician
NPI: 1073596706Individual
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
036047780(IL)01026618A(IN)
Research & Publications (16)
Biliary sequelae following radioembolization with Yttrium-90 microspheres.
PMID 18440457·J Vasc Interv Radiol·2008
8-other
Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
PMID 19267416·Cancer·2009
3-trial
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
PMID 18027884·Hepatology·2008
3-trial
Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres.
PMID 18231857·Dig Dis Sci·2008
3-trial
Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
PMID 18309018·Radiology·2008
8-other
Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
PMID 18349311·Radiology·2008
8-other
Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
PMID 18656011·J Vasc Interv Radiol·2008
3-trial
Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
PMID 18838878·Am J Clin Oncol·2008
3-trial
A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.
PMID 17911515·J Vasc Interv Radiol·2007
3-trial
Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
PMID 18003987·J Vasc Interv Radiol·2007
3-trial
Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.
PMID 17280504·Future Oncol·2007
6-review
90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
PMID 17494843·J Vasc Interv Radiol·2007
3-trial
Technical aspects of radioembolization with 90Y microspheres.
PMID 17980315·Tech Vasc Interv Radiol·2007
6-review
Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.
PMID 17048240·J Surg Oncol·2006
8-other
Angiographic considerations in patients undergoing liver-directed therapy.
PMID 16002500·J Vasc Interv Radiol·2005
6-review
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
PMID 16371529·J Vasc Interv Radiol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 10350 HALIGUS RD STE 200
HUNTLEY, IL 60142 - Phone
- (815) 338-6600
Quick Facts
- NPI
- 1073596706
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 16
Are you this provider?
Claim Your Profile